<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cocaine: Acute intoxication</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cocaine: Acute intoxication</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cocaine: Acute intoxication</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lewis S Nelson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Oladapo Odujebe, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Stolbach, MD, MPH, FAACT, FACMT, FACEP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michele M Burns, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Grayzel, MD, FAAEM</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cocaine, purported to be the most potent stimulant of natural origin, is extracted from the leaves of the coca plant (Erythroxylum coca), which is indigenous to the Andean highlands of South America. Natives in this region chew or brew coca leaves into a tea for refreshment and to relieve fatigue, similar to the customs of chewing tobacco and drinking tea or coffee in other cultures.</p><p>Pure cocaine was first isolated in the 1880s and was first used as a local anesthetic in eye surgery. It was particularly useful in surgery of the nose and throat because of its ability to provide anesthesia and constrict blood vessels, thereby limiting bleeding. Cocaine was legal and widely used in the United States during the second half of the 19<sup>th</sup> century and was a main ingredient of the original Coca-Cola. Despite legislative attempts dating from the early 20<sup>th</sup> century to eradicate its use, cocaine remains a common and dangerous drug of abuse.</p><p>This topic review will discuss the basic pharmacology, clinical presentation, and management of acute cocaine intoxication. Treatment for chronic cocaine abuse, general management of acute drug overdose, and other aspects of drug abuse are discussed elsewhere. A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef70334" href="/d/graphic/70334.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a> and  <a class="medical medical_review" href="/d/html/4343.html" rel="external">"Pulmonary complications of cocaine use"</a> and  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Cocaine remains among one of the most common causes of acute drug-related emergency department visits in the United States. It accounts for more reports to the Drug Abuse Warning Network (DAWN) than marijuana, synthetic marijuana, or hashish the next leading causes [<a href="#rid1">1</a>]. Death from unintentional cocaine overdose and cocaine-related violence occurs throughout the world [<a href="#rid2">2-5</a>]. The epidemiology of cocaine use, including morbidity and mortality, is reviewed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PHARMACOLOGY</span><span class="headingEndMark"> — </span>Cocaine is well-absorbed following contact with the oral, nasal, gastrointestinal, rectal, and vaginal mucosa, or via the pulmonary alveoli following inhalation. Cocaine's vasoconstrictive properties prolong the rate of absorption and delay its peak effect when absorbed from mucosal surfaces. The bioavailability of cocaine is approximately 90 percent when smoked and about 80 percent after intranasal use. Bioavailability is decreased when cocaine is ingested, though this is not well studied [<a href="#rid6">6</a>].</p><p>The alkaloidal form of cocaine is extracted from the coca leaf by mechanical degradation in the presence of a hydrocarbon solvent. The resultant product is converted into a hydrochloride salt and extracted into an aqueous phase, from which water is subsequently evaporated to yield a white powder (cocaine hydrochloride).</p><p>Smokeable cocaine is formed by dissolving the hydrochloride form of cocaine in water and adding a strong base. A hydrocarbon solvent is then added, the cocaine base is extracted into the organic phase, and the solvent then evaporated. "Free-basing" is a term used to refer to smoking or inhaling cocaine base following extraction and usually done on an individual basis. "Crack" is an analogous compound used in solid form that is produced on a commercial, though illegal, level.</p><p class="headingAnchor" id="H4"><span class="h1">KINETICS</span><span class="headingEndMark"> — </span>A table summarizing the time of onset, time to peak action, and duration of action for various routes of exposure is provided  (<a class="graphic graphic_table graphicRef57492" href="/d/graphic/57492.html" rel="external">table 2</a>). These parameters were determined in volunteers with a history of cocaine use, by administering cocaine via the various routes and measuring serum concentrations. The half-life of cocaine metabolites and their elimination times were noted [<a href="#rid6">6</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Metabolites – There are three major metabolites of cocaine: benzoylecgonine (BE) formed from spontaneous hydrolysis (&gt;50 percent), ecgonine methyl ester (EME) formed from metabolism by plasma pseudocholinesterase (32 to 49 percent), and norcocaine formed from metabolism by the p450 system (N-demethylation) (5 percent) [<a href="#rid7">7</a>]. </p><p></p><p class="bulletIndent1">BE is a potent vasoconstrictor in vitro. BE and EME have poor blood-brain barrier penetration, so central neurologic effects are related to cocaine that enters the central nervous system prior to metabolism. EME is a vasodilator, sedative, and anticonvulsant, and is protective against lethal doses of cocaine [<a href="#rid8">8-10</a>]. In vitro, BE has minimal effect on cardiac sodium and potassium channels and in animal models it is virtually inactive [<a href="#rid11">11</a>]. The metabolite anhydroecgonine methyl ester (AEME), or methylecgonine, is formed by pyrolysis (superheating) of cocaine. It has muscarinic receptor (M2) agonist properties that may contribute to bronchospasm.</p><p></p><p>A transesterification reaction between ethanol and cocaine produces a unique agent, benzoylmethylecgonine, also called cocaethylene or ethyl cocaine [<a href="#rid12">12</a>]. In healthy volunteers given cocaine and ethanol, cocaethylene accounted for up to 17 percent of the metabolites [<a href="#rid13">13</a>]. Cocaethylene has a long duration of action (up to 13 hours depending on the route of administration [<a href="#rid14">14</a>]), and like cocaine, is vasoconstrictive, cardiotoxic, dysrhythmogenic, and neurotoxic [<a href="#rid15">15,16</a>]. Cocaethylene is as potent as cocaine at inhibiting <a class="drug drug_general" data-topicid="9384" href="/d/drug information/9384.html" rel="external">dopamine</a> reuptake [<a href="#rid17">17</a>]. </p><p>The serum concentration of cocaethylene varies by the route of administration of cocaine. Approximately 24 percent of cocaine is converted to cocaethylene when administration is intravenous (IV), 18 percent when the drug is insufflated and 34 percent when cocaine is used orally. The physiologic effects of cocaethylene typically outlast the effects that would have been observed if cocaine alone was used by any of the common routes of administration [<a href="#rid14">14</a>]. </p><p>Cocaine's volume of distribution is about 2.7 L/kg, and it is about 90 percent protein bound. It is unclear whether these values change in overdose states [<a href="#rid6">6</a>]. The serum half-life of cocaine is 0.5 to 1.5 hours. A minor amount is excreted unchanged in the urine [<a href="#rid18">18</a>]. BE and EME are excreted in the urine, and have serum half-lives of 5 to 8 hours and 3.5 to 6 hours, respectively [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H5"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Cocaine's effects occur primarily via three mechanisms, which are discussed below.</p><p class="bulletIndent1"><span class="glyph">●</span>Blockade of reuptake of biogenic amines – Cocaine is an indirect sympathomimetic agent, which increases the availability of biogenic amines at adrenergic receptors by blocking their presynaptic reuptake. These effects are described in neurons containing serotonin and catecholamines (ie, <a class="drug drug_general" data-topicid="9384" href="/d/drug information/9384.html" rel="external">dopamine</a>, norepinephrine, and epinephrine) [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent1">Cocaine stimulates alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors through increased levels of norepinephrine, and to a lesser extent epinephrine. Cocaine has preferential alpha-receptor activity on the cardiac and peripheral vasculature and additional cardiac effects through beta-adrenergic agonism. The alpha-adrenergic agonist effects of norepinephrine cause vasoconstriction in both cardiac and peripheral vasculature.</p><p></p><p class="bulletIndent1">The euphoric properties of cocaine derive from the inhibition of neuronal serotonin reuptake in the central nervous system, while addiction has been linked to effects on <a class="drug drug_general" data-topicid="9384" href="/d/drug information/9384.html" rel="external">dopamine</a> reuptake. In animal studies, effects on the dopamine-containing neuronal systems traveling from the limbic region to the frontal cortex are strongly associated with cocaine addiction [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sodium (Na+) channel blockade – Cocaine slows or blocks nerve conduction and acts as a local anesthetic by altering the recovery of the neuronal Na+ channels. Local anesthetics block conduction by decreasing or preventing the large transient increase in the permeability of excitable membranes to Na+ that normally is produced by a slight depolarization of the membrane. Cocaine has similar effects on cardiac Na+ channels and is able to slow Na+ current in cardiac myocytes. With severe overdose, these cardiac Na+ channel effects manifest on an electrocardiogram as prolongation of the QRS complex, and clinically as negative inotropy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Excitatory amino acid stimulation – Cocaine increases the concentration of the excitatory amino acids glutamate and aspartate in the brain, particularly in the nucleus accumbens [<a href="#rid22">22</a>]. Glutamate is the main excitatory neurotransmitter of the central nervous system [<a href="#rid23">23</a>]. Aspartate has similar actions, although its exact role as a neurotransmitter is not as well defined; it is only active at certain subtypes of glutamate receptors [<a href="#rid24">24</a>]. Aspartate also serves as a precursor for glutamate.</p><p></p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Cocaine produces a dose-dependent increase in heart rate and blood pressure accompanied by increased arousal, improved performance on tasks of vigilance and alertness, and a sense of self-confidence, euphoria, and well-being. Use is typically followed by a craving for more of the drug. Cocaine produces end-organ toxicity in virtually every organ system in the body, primarily through its hemodynamic effects.</p><p class="headingAnchor" id="H5429611"><span class="h2">Cardiovascular</span><span class="headingEndMark"> — </span>Acute cocaine use is associated with arterial vasoconstriction and enhanced thrombus formation [<a href="#rid25">25-27</a>]. It causes tachycardia, hypertension, increased myocardial oxygen demand, and increased vascular shearing forces. Cocaine causes coronary vasoconstriction in a dose-dependent fashion and is associated with cardiac ischemia in 5 to 6 percent of patients with cocaine-related visits to the emergency department (ED) [<a href="#rid28">28</a>]. At high blood concentrations, cocaine's negative inotropic effects may cause acute depression of left ventricular function and heart failure [<a href="#rid29">29</a>]. Cocaine can cause supraventricular and ventricular dysrhythmias through direct actions at myocardial receptors or as a complication of myocardial ischemia. Aortic dissection and rupture occur rarely after cocaine use [<a href="#rid30">30</a>]. (See <a class="local">'Pathophysiology'</a> above.)</p><p>Chronic cocaine use can cause accelerated atherogenesis [<a href="#rid31">31,32</a>] and left ventricular hypertrophy, which increase the risk of myocardial ischemia or infarction, and can lead to dilated cardiomyopathy. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a>.)</p><p class="headingAnchor" id="H5429618"><span class="h2">Central nervous system</span><span class="headingEndMark"> — </span>Cocaine can cause a variety of central nervous system (CNS) complications including psychomotor agitation, seizures, coma, headache, intracranial hemorrhage, and focal neurologic symptoms [<a href="#rid15">15</a>]. Cocaine-induced psychomotor agitation can cause hyperthermia when peripheral vasoconstriction prevents the body from dissipating the heat being generated from persistent agitation. Mortality can be as high as 33 percent when hyperthermia develops in the setting of cocaine intoxication [<a href="#rid33">33</a>].</p><p>Psychomotor agitation occurs via several mechanisms. Cocaine causes an increase in the CNS excitatory amino acids glutamate and aspartate, and release of the excitatory neurotransmitters norepinephrine, serotonin, and <a class="drug drug_general" data-topicid="9384" href="/d/drug information/9384.html" rel="external">dopamine</a>. The hyperthermia seen in cocaine-intoxicated patients is directly related to the extent of their psychomotor agitation and the ambient temperature [<a href="#rid33">33</a>]. (See <a class="local">'Pathophysiology'</a> above.)</p><p>Seizures occur in approximately 3 to 4 percent of cocaine-related ED visits following acute or chronic use [<a href="#rid29">29,34</a>]. Seizures may occur after large doses in patients without an underlying seizure focus [<a href="#rid29">29</a>]. </p><p>Cocaine is associated with both focal neurologic deficits and coma. Possible etiologies include vasoconstriction (ie, transient ischemic attack or ischemic stroke) and intracerebral hemorrhage. Numerous reports describe patients with subarachnoid, intraventricular, and intraparenchymal bleeding associated with cocaine use [<a href="#rid35">35-38</a>]. Other neurologic complications, such as paralysis from vasospasm-induced anterior spinal cord syndrome, occur rarely [<a href="#rid35">35</a>].</p><p>Headaches occur often and are likely due to neurotransmitter dysregulation or hemodynamic alterations [<a href="#rid15">15,39</a>]. Occipital or bilateral headaches that begin immediately after use and persist up to 48 hours can develop in individuals who use cocaine intravenously (IV), while throbbing frontal headaches can develop in individuals who use cocaine intranasally. Individuals who smoke crack cocaine can develop either type. Headaches are often accompanied by nausea and vomiting.</p><p>Cocaine may cause psychotic symptoms, possibly including paranoia, delusions, or hallucinations, which may resemble the positive symptoms of schizophrenia. Cocaine-related psychosis is discussed separately. (See  <a class="medical medical_review" href="/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis", section on 'Psychiatric effects'</a>.)</p><p class="headingAnchor" id="H5429625"><span class="h2">Pulmonary</span><span class="headingEndMark"> — </span>Crack cocaine requires high temperatures to be vaporized and smoked. Angioedema and pharyngeal burns can occur when crack cocaine is smoked. Injury to the upper and lower airway occurs primarily from inhalation of heated fumes and is not a direct toxic effect of the drug. Alveolar hemorrhage can result. The pulmonary complications of cocaine use are reviewed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/4343.html" rel="external">"Pulmonary complications of cocaine use"</a>.)</p><p>Intranasal and inhalational cocaine use is associated with pneumothorax, pneumomediastinum, and pneumopericardium [<a href="#rid40">40-42</a>]. These complications result from the Valsalva maneuver applied by the user to avoid exhaling the drug. </p><p>Cocaine is associated with exacerbations of reversible airway disease and bronchospasm [<a href="#rid43">43-45</a>]. Crack lung can also cause shortness of breath. </p><p>Cocaine use is associated with vasoconstriction [<a href="#rid25">25</a>], vasospasm, and enhanced thrombus formation [<a href="#rid26">26</a>]. This predisposes patients who use cocaine to pulmonary infarction. Patients with this complication usually present with shortness of breath and pleuritic chest pain, as well as the other findings that may be confused with pulmonary embolism [<a href="#rid46">46,47</a>]. It is not known whether the risk of pulmonary embolism is increased among cocaine abusers.</p><p class="headingAnchor" id="H5429632"><span class="h2">Gastrointestinal and renal</span><span class="headingEndMark"> — </span>Cocaine users have a disproportionate incidence of perforated ulcers. Possible mechanisms include increased sympathetic tone causing increased gastric acid production or local ischemia in the gastrointestinal tract [<a href="#rid48">48-50</a>]. Cocaine is also implicated in cases of ischemic colitis, intestinal infarction, and metabolic acidosis. Patients presenting with signs and symptoms of bowel obstruction may be engaged in body packing [<a href="#rid15">15</a>]. (See <a class="local">'Body packers and stuffers'</a> below.)</p><p>Although less common, infarction of the spleen or kidney can occur from cocaine use [<a href="#rid51">51,52</a>]. In cocaine users, minor abnormalities of liver enzymes are common and rarely associated with symptoms [<a href="#rid53">53</a>]. More severe hepatic failure can be seen following hyperthermia due to psychomotor agitation. (See <a class="local">'Central nervous system'</a> above.)</p><p class="headingAnchor" id="H5429639"><span class="h2">Other organ systems and complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Musculoskeletal</strong> – Patients with cocaine toxicity can present with a spectrum of musculoskeletal concerns. Signs can range from mild creatine phosphokinase and myoglobin elevation to electrolyte alterations (hyperkalemia, hypocalcemia) seen with rhabdomyolysis. Patients can demonstrate a range of complications from localized or diffuse muscle pain to frank compartment syndrome [<a href="#rid15">15,54</a>]. Patients with severe rhabdomyolysis may have a lactic acidosis, life-threatening hyperkalemia, and acute kidney injury. (See  <a class="medical medical_review" href="/d/html/5169.html" rel="external">"Rhabdomyolysis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/14036.html" rel="external">"Prevention and treatment of heme pigment-induced acute kidney injury (including rhabdomyolysis)", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ophthalmologic</strong> – Sympathetic stimulation causes mydriasis through activation of the dilator fibers of the iris. The pupil usually maintains its ability to constrict to light. Cocaine, like other mydriatic agents, can cause acute angle-closure glaucoma, and vasospasm of the retinal vessels can produce unilateral or bilateral vision loss [<a href="#rid55">55,56</a>]. Patients who smoke crack cocaine may develop mydriasis (unilateral or bilateral), suffer corneal epithelial destruction, or singe their eyebrows and lashes (madarosis) due to heat or direct topical effects [<a href="#rid15">15,57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy (pre and postnatal exposure)</strong> – Chronic cocaine use during pregnancy is associated with problems in fetal development [<a href="#rid58">58</a>]. Acute cocaine exposure in pregnancy is associated with abruptio placentae [<a href="#rid59">59</a>]. The effects of in-utero cocaine exposure are discussed more extensively elsewhere. (See  <a class="medical medical_review" href="/d/html/128152.html" rel="external">"Substance use during pregnancy: Overview of selected drugs", section on 'Opioids'</a> and  <a class="medical medical_review" href="/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis", section on 'Cocaine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Passive cocaine exposure</strong> – Children and elderly patients can present with signs and symptoms of cocaine intoxication and/or complications of cocaine exposure by proximity to users of inhalational cocaine. Cocaine exposure can also occur via ingestion of cocaine or crack, typically when cocaine is left within a child's reach. The incidence of unintentional cocaine exposure may be as high as 5 percent among all children presenting to urban EDs [<a href="#rid60">60</a>]. (See <a class="local">'Pediatric considerations'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hematologic and other effects of adulterants</strong> ‒ Levamisole, an immunomodulator, has been found in cocaine and can cause agranulocytosis, leukoencephalopathy, and cutaneous vasculitis, possible leading to cutaneous necrosis. Clenbuterol, another adulterant, can cause tachycardia, hyperglycemia, palpitations, and hypokalemia. (See <a class="local">'Adulterants and their effects'</a> below.)</p><p></p><p class="headingAnchor" id="H5429510"><span class="h1">ADULTERANTS AND THEIR EFFECTS</span></p><p class="headingAnchor" id="H5429517"><span class="h2">Levamisole</span><span class="headingEndMark"> — </span>Levamisole is a common adulterant of cocaine that can cause agranulocytosis, leukoencephalopathy, or cutaneous vasculitis, possibly leading to cutaneous necrosis [<a href="#rid61">61-67</a>]. (See  <a class="medical medical_review" href="/d/html/8374.html" rel="external">"Drug-induced neutropenia and agranulocytosis", section on 'Cocaine and heroin'</a> and  <a class="medical medical_review" href="/d/html/16556.html" rel="external">"Approach to the patient with retiform (angulated) purpura", section on 'Other'</a>.)</p><p>A review of published cases of levamisole-related toxicity noted that 52 percent of these patients presented with oropharyngeal complaints, while 27 percent presented with soft tissue infections or purpura [<a href="#rid68">68-70</a>]. Exposure to cocaine adulterated with levamisole should be suspected in patients with these entities or complaints. Levamisole was used as an adjuvant treatment for colon cancer and an immunomodulator for various conditions and is now used primarily in veterinary practice as an anthelminthic agent [<a href="#rid71">71</a>]. A small case series describes an association between levamisole and hyponatremia, but this phenomenon has yet to be formally studied [<a href="#rid72">72</a>]. </p><p>The United States Drug Enforcement Agency first noted levamisole mixed with cocaine in 2003 and beginning in 2008 investigators in New Mexico reported that some patients who had been exposed to cocaine were developing agranulocytosis (confirmed by bone marrow histopathology). In 2008, levamisole was found in about 44 percent of seized cocaine, and by 2009, this amount rose to 69 to 73 percent [<a href="#rid71">71</a>]. In 2010, investigators in Colorado found that 78 percent of patients with a urine drug screen positive for cocaine also tested positive for levamisole [<a href="#rid61">61</a>]. In Europe and around the world, levamisole is widely used as a cutting agent for cocaine [<a href="#rid73">73,74</a>].</p><p class="headingAnchor" id="H5429582"><span class="h2">Clenbuterol</span><span class="headingEndMark"> — </span>Clenbuterol, a beta adrenergic agonist, has been found as an adulterant in cocaine and heroin. It can cause hyperglycemia and hypokalemia.</p><p>In early 2005, cases were reported in the northeastern and southern United States describing a number of patients with atypical presentations following heroin or cocaine use [<a href="#rid75">75</a>]. The most common findings were tachycardia (89 percent), hyperglycemia (78 percent), palpitations (78 percent), and hypokalemia (78 percent). In one case series, 67 percent of the patients had all four findings. Other common findings included nausea, hypotension, chest pain, venous hyperoxia, lactic acidosis, agitation, and anxiety. Investigators attributed these symptoms to the heroin and cocaine supply being adulterated with clenbuterol.</p><p class="headingAnchor" id="H4237093972"><span class="h2">Fentanyl</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">Fentanyl</a> is increasingly found as an adulterant of cocaine [<a href="#rid76">76,77</a>] and crack cocaine [<a href="#rid78">78,79</a>], leading to life-threatening opioid poisoning in many cases. In a recent cluster, 18 patients, primarily middle-aged men without a history of prior opioid use, presented with an opioid toxidrome (ie, lethargy, respiratory depression, and pinpoint pupils) following cocaine use [<a href="#rid78">78</a>]. Most patients responded to <a class="drug drug_general" data-topicid="9678" href="/d/drug information/9678.html" rel="external">naloxone</a>; three patients died. Testing confirmed cocaine use in 16 patients and fentanyl exposure in 15. Investigation could not determine whether fentanyl adulteration was intentional or incidental. (See  <a class="medical medical_review" href="/d/html/300.html" rel="external">"Acute opioid intoxication in adults", section on 'Fentanyl and fentanyl analogs'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Acute cocaine intoxication is most notable for psychomotor agitation, a common, important feature of many intoxication and disease states  (<a class="graphic graphic_table graphicRef142894" href="/d/graphic/142894.html" rel="external">table 3</a>).</p><p>Drug-related intoxications, syndromes, and withdrawal states that may be mistaken for acute cocaine intoxication include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Amphetamine intoxication (see  <a class="medical medical_review" href="/d/html/82952.html" rel="external">"Acute amphetamine and synthetic cathinone ("bath salt") intoxication"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Synthetic cathinone intoxication</p><p class="bulletIndent1"><span class="glyph">●</span>Phencyclidine intoxication (see  <a class="medical medical_review" href="/d/html/313.html" rel="external">"Phencyclidine (PCP) intoxication in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Synthetic cannabinoid intoxication (see  <a class="medical medical_review" href="/d/html/97100.html" rel="external">"Synthetic cannabinoids: Acute intoxication"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol and sedative-hypnotic withdrawal syndromes (see  <a class="medical medical_review" href="/d/html/323.html" rel="external">"Management of moderate and severe alcohol withdrawal syndromes"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Serotonin syndrome (see  <a class="medical medical_review" href="/d/html/301.html" rel="external">"Serotonin syndrome (serotonin toxicity)"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Neuroleptic malignant syndrome (see  <a class="medical medical_review" href="/d/html/4829.html" rel="external">"Neuroleptic malignant syndrome"</a>)</p><p></p><p>Diseases and medical conditions that may be mistaken for acute cocaine intoxication include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoglycemia (see  <a class="medical medical_review" href="/d/html/1763.html" rel="external">"Hypoglycemia in adults without diabetes mellitus: Clinical manifestations, causes, and diagnosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoxia (see  <a class="medical medical_review" href="/d/html/1647.html" rel="external">"Measures of oxygenation and mechanisms of hypoxemia"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Heat-related illness (see  <a class="medical medical_review" href="/d/html/176.html" rel="external">"Severe nonexertional hyperthermia (classic heat stroke) in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid storm (see  <a class="medical medical_review" href="/d/html/7885.html" rel="external">"Thyroid storm"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Subarachnoid hemorrhage (see  <a class="medical medical_review" href="/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Infections of the central nervous system (ie, meningitis and encephalitis) (see  <a class="medical medical_review" href="/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Seizures (see  <a class="medical medical_review" href="/d/html/2220.html" rel="external">"Overview of the management of epilepsy in adults"</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Several psychiatric diseases</p><p></p><p>Most of the diagnoses listed above can be distinguished from acute cocaine intoxication based on the patient's medical history and physical examination. A review of the patient's medications and a detailed account of their substance abuse preferences through family, friends, and first responders, may provide valuable clues. Necessary diagnostic testing may include computed tomography (CT) scan of the head and lumbar puncture as appropriate. We discourage indiscriminate drug testing as a means to differentiate diagnostic possibilities because of the high rate of clinically false positive results and adulterants that may be misleading. (See  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a> and  <a class="medical medical_review" href="/d/html/13846.html" rel="external">"Testing for drugs of abuse (DOAs)"</a>.)</p><p>Other diagnostic possibilities include cardiopulmonary disease, such as acute coronary syndrome, pulmonary embolus, aortic dissection, and pneumothorax. These diagnoses are generally identified through standard tests such as an electrocardiogram, chest radiograph, echocardiography, chest CT, or cardiac biomarkers. (See  <a class="medical medical_review" href="/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department"</a> and  <a class="medical medical_review" href="/d/html/8253.html" rel="external">"Epidemiology and pathogenesis of acute pulmonary embolism in adults"</a> and  <a class="medical medical_review" href="/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection"</a> and  <a class="medical medical_review" href="/d/html/6706.html" rel="external">"Pneumothorax in adults: Epidemiology and etiology"</a>.)</p><p>In most situations, general supportive care with sedation, cooling, and intravenous (IV) fluids is appropriate while diagnostic testing is performed.</p><p class="headingAnchor" id="H8"><span class="h1">LABORATORY AND RADIOGRAPHIC EVALUATION</span></p><p class="bulletIndent1"><span class="glyph">●</span>General testing – Routine laboratory evaluation in the potentially poisoned patient should include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">Acetaminophen</a> and salicylate levels, to rule out these common coingestants if the circumstances suggest self-harm</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Electrocardiogram (ECG), to rule out conduction system poisoning by drugs that effect the QRS or QTc intervals; cocaine can cause ECG changes due to its sodium channel effects or from ischemia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pregnancy test in women of childbearing age</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Specific testing – Benzoylecgonine (BE), the major urinary metabolite of cocaine, is the analyte usually tested for in blood, urine, saliva, hair, and meconium. Cocaine is rapidly metabolized and detectable in blood and urine only briefly (ie, several hours) after use. BE can be detected in the urine for several days following intermittent use and up to 10 days or more after heavy use.</p><p></p><p class="bulletIndent1">Although the assay for BE is highly accurate, false negatives may occur, albeit rarely. A drug assay "positive for cocaine" does not necessarily connote acute cocaine use due to BE's prolonged presence. BE is not a psychostimulant and can cause a clinical false positive result (ie, patient's symptoms are mistakenly attributed to acute cocaine intoxication). Analytical false positives are rare, as xenobiotics are not inappropriately detected by the BE immunoassay. Should test results and clinical findings be inconsistent, clinicians should discuss the matter with their laboratory director to determine what xenobiotics may have caused false results. Gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry is the gold standard for testing for cocaine and its metabolites. This usually requires that the specimen be sent to a specialized laboratory.</p><p></p><p>Radiographs can play a role in the detection of body stuffing and packing. (See <a class="local">'Body packers and stuffers'</a> below.)</p><p>Additional laboratory and radiographic testing can be helpful depending on the clinical setting. As examples, a troponin, creatine kinase, ECG, and chest radiograph are obtained in a patient with chest pain, creatine kinase and urine myoglobin are obtained in a patient at risk for rhabdomyolysis, and a CT of the head, followed by cerebrospinal fluid analysis if the CT is nondiagnostic, is obtained in a patient with symptoms concerning for intracranial hemorrhage.</p><p class="headingAnchor" id="H9"><span class="h1">INITIAL MANAGEMENT</span><span class="headingEndMark"> — </span>General management of the overdose patient is discussed elsewhere (see  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a>). Specific management strategies for cocaine overdose are discussed below. A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef70334" href="/d/graphic/70334.html" rel="external">table 1</a>). The management of myocardial infarction diagnosed in the setting of cocaine intoxication is reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Airway and breathing</span><span class="headingEndMark"> — </span>Supplemental oxygen should be administered only as needed. If rapid sequence tracheal intubation is necessary, we suggest that <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> <strong>not</strong> be used. Plasma cholinesterase (PChE) metabolizes both succinylcholine and cocaine, and coadministration of succinylcholine can prolong the effects of cocaine and the paralysis from succinylcholine [<a href="#rid15">15</a>]. In the setting of rhabdomyolysis and hyperthermia, succinylcholine may worsen hyperkalemia and cause life-threatening arrhythmias [<a href="#rid15">15</a>].</p><p>We suggest using a nondepolarizing neuromuscular blocker, such as <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>, if paralysis is indicated. Acceptable induction agents in cocaine-intoxicated patients include: benzodiazepines, <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a>, or <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>. (See  <a class="medical medical_review" href="/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Cardiovascular complications</span></p><p class="headingAnchor" id="H3931293201"><span class="h3">Approach to management</span><span class="headingEndMark"> — </span>Most cardiovascular stimulation from cocaine is centrally mediated via the sympathetic nervous system. As such, sedation with a benzodiazepine, using an appropriate dose and route of administration, is first-line therapy for cardiovascular complications stemming from acute cocaine intoxication. Benzodiazepine therapy is generally sufficient to alleviate cardiovascular symptoms and signs. The dosing of benzodiazepines used for psychomotor agitation is described below, and such dosing is appropriate for the treatment of cardiovascular symptoms and signs. (See <a class="local">'Psychomotor agitation'</a> below.) </p><p>In patients with refractory or symptomatic cocaine-induced hypertension, <a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a> can be used to counteract the alpha-adrenergic vasoconstrictive effects of cocaine (caused by norepinephrine release). However, the use of alpha-adrenoceptor blocking agents, such as phentolamine, may cause an increase in heart rate [<a href="#rid80">80</a>]. Suitable alternative medications for the management of refractory hypertension include vasodilators without beta blocking effects, such as <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> or <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>. Phentolamine is given as an intravenous (IV) bolus. The usual dose is 5 to 15 mg IV every 5 to 15 minutes as necessary. We prefer to start with lower doses and titrate to the desired blood pressure. </p><p>We recommend that beta-adrenergic antagonists (ie, beta-blockers), including mixed alpha/beta blockers such as <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> and <a class="drug drug_general" data-topicid="9208" href="/d/drug information/9208.html" rel="external">carvedilol</a>, not be used for cardiovascular complications associated with acute cocaine intoxication. The use of beta blockers and chest pain associated with cocaine intoxication are discussed further below. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a> and <a class="local">'Use of beta adrenergic antagonists (beta blockers)'</a> below and <a class="local">'Chest pain'</a> below.)</p><p>Hypertensive emergencies can be seen in the setting of acute cocaine intoxication and are usually defined as an elevated blood pressure associated with end-organ damage. There are no treatment goals specifically defined for cocaine-related hypertensive emergencies, but the initial aim of treatment in general hypertensive crises is to lower the diastolic pressure rapidly to about 100 to 105 mmHg; this goal should be achieved within 2 to 6 hours, with the maximum initial fall in mean arterial blood pressure not exceeding 25 percent of the presenting value. Cocaine-related hypertension should be treated judiciously given its usually self-limited nature (hypertension generally resolves when cocaine is metabolized) and the importance of avoiding hypotension. Treatment with benzodiazepines, possibly in conjunction with the medications discussed above (<a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a>, <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a>, or <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>), is sufficient in most cases. Hypertensive emergencies are discussed separately. (See  <a class="medical medical_review" href="/d/html/3833.html" rel="external">"Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults", section on 'Goal of therapy'</a> and  <a class="medical medical_review" href="/d/html/3837.html" rel="external">"Evaluation and treatment of hypertensive emergencies in adults"</a>.)</p><p>If a patient no longer appears acutely agitated and other signs of sympathetic excess (eg, tachycardia, diaphoresis) have resolved, but significant hypertension persists, acute cocaine exposure is unlikely to be the cause. In such cases, hypertension should be managed based upon the patient’s medical comorbidities and clinical status. </p><p>Cocaine toxicity usually causes hypertension, but massive toxicity may result in hypotension due to myocardial sodium-channel blockade, cardiac dysrhythmias, or cardiac ischemia. Patients with hypotension should be treated with IV isotonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>. If hypotension persists after 2 to 3 L of rapidly infused isotonic saline, direct-acting vasopressors such as norepinephrine or <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a> can be given and titrated to effect. An electrocardiogram (ECG) should be obtained, and if there are signs of QRS widening (suggesting sodium channel blockade), hypertonic <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> should be administered at a dose of 1 to 2 mEq/kg by bolus via a large bore IV. A repeat ECG should be obtained to evaluate whether QRS narrowing has occurred in response to treatment. (See  <a class="medical medical_review" href="/d/html/295.html" rel="external">"Tricyclic antidepressant poisoning", section on 'Sodium bicarbonate for cardiac toxicity'</a>.)</p><p>Management of patients suspected to be body packers or stuffers is discussed briefly below and in detail separately. (See <a class="local">'Body packers and stuffers'</a> below and  <a class="medical medical_review" href="/d/html/327.html" rel="external">"Internal concealment of drugs of abuse (body packing)"</a>.)</p><p class="headingAnchor" id="H1851443538"><span class="h3">Use of beta adrenergic antagonists (beta blockers)</span><span class="headingEndMark"> — </span>We recommend that beta-blockers not be used to treat cardiovascular complications, particularly myocardial ischemia, in patients with <strong>acute</strong> cocaine intoxication. This proscription in the acute setting is based principally upon concerns of coronary artery vasoconstriction and systemic hypertension, which can result from unopposed alpha-adrenergic stimulation. Details pertaining specifically to the issue of beta blockers therapy in the setting of cocaine use, and more generally to the diagnosis and management of the cardiovascular complications of cocaine use, are reviewed separately. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a>.) </p><p>Note that labetolol (a mixed alpha/beta antagonist with predominantly beta-blocking effects) is included among the medications proscribed, although several articles suggest that mixed alpha/beta blockers, including <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> and <a class="drug drug_general" data-topicid="9208" href="/d/drug information/9208.html" rel="external">carvedilol</a>, may be safe and effective in these patients [<a href="#rid81">81-83</a>]. We acknowledge that available evidence pertaining directly to this clinical scenario is weak [<a href="#rid80">80,84,85</a>]. The data are even less clear for patients with cocaine-related chest pain or acute coronary syndrome who are not manifesting signs of acute cocaine toxicity.</p><p>We believe, based on the available evidence and our clinical experience, that optimal therapy for patients experiencing cardiovascular complications in the setting of acute cocaine intoxication begins with reduction in central nervous system catecholamine release, rather than peripheral antagonism of released catecholamines, and that benzodiazepines have a proven role in this regard [<a href="#rid86">86,87</a>]. (See <a class="local">'Psychomotor agitation'</a> below.)</p><p>Nevertheless, due to increasing evidence of safety [<a href="#rid88">88</a>], some clinicians may choose to give beta blockers as part of their management of acute cocaine-related cardiovascular complications. Should beta blockade be performed in this setting, it should be done cautiously, ideally in combination with an alpha antagonist or some other vasodilator without beta blocking effects (eg, <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> or <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>), and under close observation, including frequent measurements of vital signs and serial ECGs. The general use of beta blockers in the settings of acute coronary syndrome and coronary heart disease is reviewed separately, as is the detailed management of cardiovascular complications from cocaine abuse. (See  <a class="medical medical_review" href="/d/html/96.html" rel="external">"Acute myocardial infarction: Role of beta blocker therapy"</a> and  <a class="medical medical_review" href="/d/html/1466.html" rel="external">"Beta blockers in the management of chronic coronary syndrome"</a> and  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a>.) </p><p class="headingAnchor" id="H12"><span class="h2">Psychomotor agitation</span><span class="headingEndMark"> — </span>Agitated patients are sedated as needed with benzodiazepines, after ensuring they are not hypoglycemic or hypoxic. We suggest <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> be given in an initial dose of 10 mg IV, then 5 to 10 mg IV every 3 to 5 minutes until agitation is controlled. Monitor patients for respiratory depression and hypotension. Intramuscular <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a> or <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> can be used if IV access is unavailable, but their peak effect is typically delayed (10 to 20 minutes).</p><p>Hyperthermic patients should be cooled rapidly, optimally in 30 minutes or less, to a goal core body temperature of &lt;102°F. Immersion in ice or ice water is the most rapid cooling method for severely hyperthermic patients; cooling via evaporative spray may be sufficient in moderately hyperthermic patients [<a href="#rid89">89-91</a>]. (See  <a class="medical medical_review" href="/d/html/176.html" rel="external">"Severe nonexertional hyperthermia (classic heat stroke) in adults"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Gastrointestinal decontamination</span><span class="headingEndMark"> — </span>Since the popular methods of cocaine use are nonenteral (ie, inhalational, IV, and intranasal), the majority of patients who present with cocaine intoxication will not require gastrointestinal decontamination [<a href="#rid34">34</a>]. Decontamination should be performed, if required, by removing any cocaine powder from nares, mouth, or oropharynx. Gentle nasal irrigation with 0.9 percent (isotonic) <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> could be used if the patient presents with a visible white powder presumed to be cocaine [<a href="#rid18">18</a>]. Activated charcoal reduces the lethality of oral cocaine [<a href="#rid92">92</a>]. The dose of activated charcoal is 1 g per kg body weight (up to 50 g) and should be administered by mouth every 4 hours for several doses. Body packing and stuffing is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/327.html" rel="external">"Internal concealment of drugs of abuse (body packing)"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SPECIFIC SYNDROMES</span></p><p class="headingAnchor" id="H16"><span class="h2">Chest pain</span><span class="headingEndMark"> — </span>Cocaine-associated chest pain (CACP) accounts for a sizeable portion of cocaine-related visits to the emergency department. Acutely, cocaine causes vasoconstriction and enhances thrombus formation, increasing the risk of myocardial ischemia. Up to 6 percent of patients presenting with CACP manifest elevations in biomarkers or other signs (eg, electrocardiogram [ECG] findings) consistent with myocardial injury. The epidemiology, presentation, and management of myocardial ischemia and other cardiovascular complications diagnosed in the setting of cocaine intoxication is reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a>.)</p><p>Although acute coronary syndrome remains an important concern, ED clinicians should avoid prematurely discounting alternative diagnoses in patients with CACP but no clear evidence of myocardial infarction. Pneumothorax and crack lung can present as chest pain following cocaine use. Other potential complications include aortic dissection, myocarditis, and arrhythmia. Complications can develop regardless of the form of cocaine use (eg, smoking, intravenous [IV], intranasal). (See <a class="local">'Crack lung and other pulmonary complications'</a> below and  <a class="medical medical_review" href="/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection"</a> and  <a class="medical medical_review" href="/d/html/4939.html" rel="external">"Clinical manifestations and diagnosis of myocarditis in adults"</a>.)</p><p>Symptoms associated with myocardial ischemia from acute cocaine use are indistinguishable from those associated with other cases. According to one retrospective cohort study, patients with CACP most commonly complain of: substernal chest pain (76 percent), shortness of breath (62 percent), tightness/pressure/squeezing (55 percent), and diaphoresis (48 percent) [<a href="#rid93">93</a>].</p><p>Evaluation of patients with CACP pain includes serial ECGs, plain chest radiograph, and biomarkers to exclude myocardial infarction. Two prospective observational studies suggest the ECG has limited accuracy in the setting of CACP, and ECG evidence of ischemia or infarction may not correlate with myocardial infarction, as diagnosed by an elevation in cardiac biomarkers [<a href="#rid28">28,94</a>]. According to these studies, the sensitivity and specificity of the ECG are approximately 36 and 90 percent respectively. However, the number of patients diagnosed with myocardial infarction in each study was small so the accuracy of the ECG in CACP remains unclear.</p><p>Early management of patients with CACP includes the administration of oxygen as necessary to maintain SpO2 ≥93 and reduction of sympathetic outflow using benzodiazepines given IV. We suggest benzodiazepines be given to patients who are anxious, agitated, hypertensive, or tachycardic; we suggest <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> be given in addition to patients with hypertension. We give <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> (5 mg IV every 3 to 5 minutes) or <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a> (1 mg IV every 5 to 10 minutes) until sedation is achieved. We give nitroglycerin 0.4 mg sublingual every 5 minutes as needed for a maximum of three doses. If additional nitroglycerin is needed, an infusion can be started with the dose titrated to effect.</p><p>The pharmacologic treatment of patients with CACP differs in several important ways from the standard treatment of myocardial ischemia from atherosclerotic coronary artery disease. Beta blockers are generally not recommended in patients who have recently used cocaine (&lt;24 hours), and in patients with CACP, although evidence is limited. Beta blockers may lead to unopposed alpha adrenergic stimulation, which can cause coronary arterial vasoconstriction, ischemia, and infarction. The use of beta blockers and other treatments for acute coronary syndrome in the setting of cocaine use is discussed separately. (See  <a class="medical medical_review" href="/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse", section on 'Treatment of cocaine-related myocardial ischemia/infarction'</a>.)</p><p><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> is contraindicated in patients suspected of having an aortic dissection, but can be given at standard doses to patients with CACP when myocardial ischemia is the suspected cause. </p><p><a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">Phentolamine</a>, an alpha-adrenergic antagonist, can be used to reduce cocaine-induced coronary artery vasoconstriction when managing CACP or hypertension that is unresponsive to benzodiazepines and <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> [<a href="#rid25">25,95-98</a>]. Phentolamine is given as an IV bolus of 1 to 2.5 mg every 5 to 15 minutes as necessary. (See <a class="local">'Cardiovascular complications'</a> above and <a class="local">'Psychomotor agitation'</a> above.)</p><p>In one prospective observational study, adult patients with no history of cocaine use were given a low dose (2 mg/kg) of intranasal cocaine while undergoing cardiac catheterization [<a href="#rid25">25</a>]. Cocaine caused an increase in heart rate, blood pressure, and coronary vascular resistance, and narrowing of the coronary artery diameter by 13 percent. Coronary artery diameter returned to baseline with the administration of <a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a>.</p><p class="headingAnchor" id="H17"><span class="h2">Crack lung and other pulmonary complications</span><span class="headingEndMark"> — </span>Several potentially severe pulmonary complications can occur from cocaine use, primarily smoking, including crack lung, eosinophilic pneumonia, pneumothorax and pneumomediastinum, alveolar hemorrhage, and chronic lung disease. The pulmonary complications of cocaine use are reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/4343.html" rel="external">"Pulmonary complications of cocaine use"</a>.) </p><p>Crack lung is a syndrome of hemorrhagic alveolitis from inhalational cocaine use. Cough and shortness of breath are common presenting symptoms. Additional signs and symptoms may include: acute lung injury, hypoxia, chest pain, hemoptysis, fever, focal infiltrates, and bronchospasm. A chest radiograph and a history of cocaine use provide the basis for diagnosis.</p><p>Initial management includes maintenance of oxygenation, ventilation, and symptomatic care. Patients with airway compromise may require endotracheal intubation. <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">Succinylcholine</a> should not be used. (See <a class="local">'Airway and breathing'</a> above.)</p><p class="headingAnchor" id="H18"><span class="h2">Body packers and stuffers</span><span class="headingEndMark"> — </span>The term "body packer" is used to refer to persons who swallow large quantities of prepackaged drugs with the intention of smuggling these drugs across international borders. Body packers have been called swallowers, internal carriers, couriers, or mules. Body stuffers are persons who swallow relatively small quantities of drugs in poorly constructed packets (usually in haste) to avoid repercussions from law enforcement agents. The presentation and management of body packers and body stuffers are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/327.html" rel="external">"Internal concealment of drugs of abuse (body packing)"</a> and  <a class="medical medical_review" href="/d/html/13845.html" rel="external">"Acute ingestion of illicit drugs (body stuffing)"</a>.)</p><p>Body packers with symptoms of acute cocaine intoxication (eg, tachycardia, hypertension, hyperthermia, agitation, seizures, or cardiac dysrhythmias) often develop life-threatening complications. The majority who sustain adverse outcomes have symptoms at presentation or within the first few hours. Management begins with stabilization of the airway, breathing, and circulation, and may involve gastrointestinal decontamination with either activated charcoal or whole bowel irrigation or both. Immediate surgical intervention to remove drug packets can be required. (See  <a class="medical medical_review" href="/d/html/327.html" rel="external">"Internal concealment of drugs of abuse (body packing)", section on 'Sympathomimetic (cocaine or amphetamine) toxicity'</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">PEDIATRIC CONSIDERATIONS</span></p><p class="headingAnchor" id="H20"><span class="h2">Presentation</span><span class="headingEndMark"> — </span>Children can present with signs and symptoms of cocaine intoxication or complications of cocaine exposure from being around adults who use cocaine [<a href="#rid60">60,99-101</a>]. Unintentional cocaine exposure in children may occur from passive inhalation of free-base cocaine vapors or ingestion. The incidence of unintentional cocaine exposure among all children treated in the emergency department may be as high as 6 percent, particularly in urban settings [<a href="#rid60">60,100,102</a>].</p><p>Observational data suggests that passive exposure to cocaine may manifest as more frequent respiratory symptoms in infants, with and without fever [<a href="#rid102">102</a>], and more frequent generalized and focal seizures in children below eight years [<a href="#rid99">99,101,103</a>]. Clinical findings in older children are similar to adults.</p><p>Fetal exposure to cocaine is discussed separately. (See  <a class="medical medical_review" href="/d/html/128152.html" rel="external">"Substance use during pregnancy: Overview of selected drugs", section on 'Cocaine'</a> and  <a class="medical medical_review" href="/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis", section on 'Cocaine'</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Specific management</span><span class="headingEndMark"> — </span>There are no special decontamination procedures in children who are exposed to cocaine. Management of children exposed to crack cocaine fumes or cocaine residue is symptomatic. In rare circumstances, children have been used to smuggle drugs from foreign countries by making them swallow packets of cocaine. (See <a class="local">'Body packers and stuffers'</a> above.)</p><p>Cocaine-exposed children may need to be admitted to the hospital. Social work and/or child protective services must be notified. The involvement of local law enforcement authorities follows local practices.</p><p class="headingAnchor" id="H22"><span class="h2">Decontamination</span><span class="headingEndMark"> — </span>Gastrointestinal decontamination is rarely needed for patients with cocaine intoxication. Should it be needed, dosing and other information is provided separately. (See  <a class="medical medical_review" href="/d/html/321.html" rel="external">"Gastrointestinal decontamination of the poisoned patient"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">DISPOSITION</span><span class="headingEndMark"> — </span>Patients with severe complications of cocaine abuse are managed as described above and admitted to the hospital at the appropriate level of care. (See <a class="local">'Initial management'</a> above.)</p><p>In general, patients who present with acute findings from cocaine toxicity that resolve are observed for 6 to 8 hours. Patients who have returned to their baseline level of function can generally be discharged after this period with appropriate referrals.</p><p>Patients who present with cocaine-associated chest pain (CACP) are observed for 8 to 12 hours while cardiac biomarkers and serial electrocardiograms (ECGs) are obtained. This assumes the patient is pain-free, or rapidly made pain-free, and has a normal initial ECG. Cardiac biomarkers are typically performed 8 to 12 hours apart. Although this is not the standard approach to the management of patients with suspected acute coronary syndromes (ACS) unrelated to cocaine, the incidence of myocardial infarction in patients with CACP is extremely low (approximately 6 percent in one study) [<a href="#rid28">28,104-107</a>]. For patients with CACP at low risk for ACS, observation in a chest pain unit is reasonable.</p><p>The results of an observational study of 59 patients with CACP at low risk for ACS suggest that such patients can be discharged safely after nonischemic ECGs, normal cardiac biomarkers, and a negative coronary computerized tomography angiography (CTA) study [<a href="#rid108">108</a>]. However, further research is needed before such an approach can be recommended.</p><p>Patients in whom cocaine use is not the sole risk factor for ACS or who have a moderate or high score on a validated cardiac risk assessment (eg, HEART or TIMI risk score) should be evaluated like any patient presenting to the emergency department with a possible ACS. (See  <a class="medical medical_review" href="/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department"</a>.)</p><p>Patients who present with psychomotor agitation, hyperthermia, or other neurological complications of cocaine toxicity may require admission for monitoring and management of sequelae. If after 6 to 8 hours of observation their symptoms are completely resolved, they are awake, alert, and ambulate without difficulty, and their reexamination reveals no concerning findings, they may discharged.</p><p class="headingAnchor" id="H89983587"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H2483183479"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H3085547522"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115010.html" rel="external">"Society guideline links: Stimulant use disorder and withdrawal"</a> and  <a class="medical medical_society_guidelines" href="/d/html/114015.html" rel="external">"Society guideline links: Treatment of acute poisoning caused by recreational drug or alcohol use"</a> and  <a class="medical medical_society_guidelines" href="/d/html/134144.html" rel="external">"Society guideline links: Cocaine use and cocaine use disorder"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Cocaine can produce end-organ toxicity in virtually every organ system primarily through hemodynamic effects. Potential effects include hypertension, arterial vasoconstriction (eg, coronary arteries), thrombus formation, psychomotor agitation (neurologic effects range from agitation to seizures to intracranial hemorrhage), severe hyperthermia, dyspnea (from pneumothorax, pulmonary infarction, or other pulmonary injury), and ischemic bowel. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Numerous drugs and disease states can mimic the cardiovascular effects and/or psychomotor agitation of acute cocaine overdose. A thorough history, including medications and preferred drugs of abuse, is often the key to diagnosis. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug testing</strong> – Benzoylecgonine (BE), the major urinary metabolite of cocaine, is the analyte usually tested for. Cocaine is rapidly metabolized and detectable in blood and urine only briefly (ie, several hours). BE can be detected in the urine for several days following intermittent use and up to 10 days or more after heavy use. Therefore, a drug assay "positive for cocaine" does not necessarily connote acute use. (See <a class="local">'Laboratory and radiographic evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency management</strong> – A summary table to facilitate emergency management is provided  (<a class="graphic graphic_table graphicRef70334" href="/d/graphic/70334.html" rel="external">table 1</a>). If rapid sequence tracheal intubation (RSI) is necessary, we suggest that <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> <strong>not</strong> be used because it can prolong the effects of cocaine and cause other complications (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). A nondepolarizing neuromuscular blocker (eg, <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>) is preferred. Acceptable induction agents include benzodiazepines, <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a>, or <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>. (See <a class="local">'Airway and breathing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular effects</strong> – Most cardiovascular stimulation from cocaine is centrally mediated via the sympathetic nervous system. We suggest initial treatment with a benzodiazepine, using an appropriate dose and route to alleviate cardiovascular symptoms (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Suitable dosing is described above (see <a class="local">'Psychomotor agitation'</a> above).</p><p></p><p class="bulletIndent1">In patients with severe, refractory, or symptomatic cocaine-induced hypertension, we suggest <a class="drug drug_general" data-topicid="9767" href="/d/drug information/9767.html" rel="external">phentolamine</a> be used to counteract the alpha-adrenergic effects of cocaine (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Phentolamine is given as an intravenous (IV) bolus. The usual dose is 5 to 15 mg every 5 to 15 minutes as necessary; we prefer to start with low doses and titrate to effect.</p><p></p><p class="bulletIndent1">We recommend that beta blockers, including <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a>, <strong>not</strong> be used in patients with acute cocaine toxicity because of the risk of cardiovascular complications from unopposed alpha-adrenergic stimulation (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>). (See <a class="local">'Cardiovascular complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Agitation</strong> – It is important to rule out hypoglycemia and hypoxia as the causes of psychomotor agitation. For cocaine-induced agitation, we suggest treatment with benzodiazepines (eg, <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> 5 to 10 mg IV every 3 to 5 minutes until agitation is controlled) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Psychomotor agitation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cocaine-associated chest pain</strong> – Chest pain is a common presentation of acute cocaine intoxication, but myocardial infarction is uncommon. Early management includes the administration of oxygen and reduction of sympathetic outflow using benzodiazepines. We suggest benzodiazepines be given to patients who are anxious, agitated, hypertensive, or tachycardic (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). We give <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> 5 mg every 3 to 5 minutes or <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a> 1 mg every 5 to 10 minutes as an IV dose until sedation is achieved. We suggest <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a> be given (in addition to a benzodiazepine) to patients with chest pain and hypertension (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Beta blockers are <strong>contraindicated</strong> in the setting of acute cocaine intoxication. (See <a class="local">'Chest pain'</a> above and <a class="local">'Cardiovascular complications'</a> above and <a class="local">'Use of beta adrenergic antagonists (beta blockers)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Crack lung</strong> – Crack lung is a syndrome of hemorrhagic alveolitis from inhalational cocaine use. Cough and shortness of breath are common presenting symptoms. Patients with airway compromise may require tracheal intubation. (See <a class="local">'Crack lung and other pulmonary complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pediatric considerations</strong> – Passive exposure to cocaine may cause more frequent respiratory symptoms in infants, with and without fever, and more frequent generalized and focal seizures in children below eight years. Clinical findings in older children are similar to adults. There are no special decontamination procedures in children. Fetal exposure to cocaine is discussed separately. (See <a class="local">'Pediatric considerations'</a> above and  <a class="medical medical_review" href="/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis", section on 'Cocaine'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disposition</strong> – Disposition strategies are discussed above. Body packers and stuffers are discussed in detail separately. (See <a class="local">'Disposition'</a> above and  <a class="medical medical_review" href="/d/html/327.html" rel="external">"Internal concealment of drugs of abuse (body packing)"</a>.)</p><p></p><p class="headingAnchor" id="H2729641748"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Stephen J Traub, MD, former section editor of the toxicology program, for 20 years of dedicated service.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">National Heroin Threat Assessment Summary April 2015 https://www.dea.gov/divisions/hq/2015/hq052215_National_Heroin_Threat_Assessment_Summary.pdf (Accessed on November 29, 2016).</li><li><a class="nounderline abstract_t">Degenhardt L, Roxburgh A, Barker B. Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. J Clin Forensic Med 2005; 12:187.</a></li><li><a class="nounderline abstract_t">Coffin PO, Galea S, Ahern J, et al. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003; 98:739.</a></li><li><a class="nounderline abstract_t">Preti A, Miotto P, De Coppi M. Deaths by unintentional illicit drug overdose in Italy, 1984-2000. Drug Alcohol Depend 2002; 66:275.</a></li><li><a class="nounderline abstract_t">Marzuk PM, Tardiff K, Leon AC, et al. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med 1995; 332:1753.</a></li><li><a class="nounderline abstract_t">Jeffcoat AR, Perez-Reyes M, Hill JM, et al. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 1989; 17:153.</a></li><li><a class="nounderline abstract_t">Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther 1978; 23:547.</a></li><li><a class="nounderline abstract_t">Hoffman RS, Kaplan JL, Hung OL, Goldfrank LR. Ecgonine methyl ester protects against cocaine lethality in mice. J Toxicol Clin Toxicol 2004; 42:349.</a></li><li><a class="nounderline abstract_t">Schuelke GS, Konkol RJ, Terry LC, Madden JA. Effect of cocaine metabolites on behavior: possible neuroendocrine mechanisms. Brain Res Bull 1996; 39:43.</a></li><li><a class="nounderline abstract_t">Schreiber MD, Madden JA, Covert RF, Torgerson LJ. Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries. J Appl Physiol (1985) 1994; 77:834.</a></li><li><a class="nounderline abstract_t">Raimo EB, Schuckit MA. Alcohol dependence and mood disorders. Addict Behav 1998; 23:933.</a></li><li><a class="nounderline abstract_t">Bourland JA, Martin DK, Mayersohn M. In vitro transesterification of cocaethylene (ethylcocaine) in the presence of ethanol. esterase-mediated ethyl ester exchange esterase-mediated ethyl ester exchange. Drug Metab Dispos 1998; 26:203.</a></li><li><a class="nounderline abstract_t">Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 2003; 72:169.</a></li><li><a class="nounderline abstract_t">Herbst ED, Harris DS, Everhart ET, et al. Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol 2011; 19:95.</a></li><li class="breakAll">Smollin CG, Hoffman RS. Cocaine. In: Goldfrank's Toxicologic Emergencies, 11th edition, Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LS, Hoffman RS (Eds), McGraw Hill, New York, NY 2019. p.1124.</li><li><a class="nounderline abstract_t">Wilson LD, French S. Cocaethylene's effects on coronary artery blood flow and cardiac function in a canine model. J Toxicol Clin Toxicol 2002; 40:535.</a></li><li><a class="nounderline abstract_t">Hearn WL, Flynn DD, Hime GW, et al. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 1991; 56:698.</a></li><li><a class="nounderline abstract_t">Jatlow PI. Drug of abuse profile: cocaine. Clin Chem 1987; 33:66B.</a></li><li><a class="nounderline abstract_t">Tella SR, Schindler CW, Goldberg SR. Cardiovascular effects of cocaine in conscious rats: relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms. J Pharmacol Exp Ther 1992; 262:602.</a></li><li><a class="nounderline abstract_t">Tella SR, Schindler CW, Goldberg SR. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther 1993; 267:153.</a></li><li><a class="nounderline abstract_t">Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237:1219.</a></li><li><a class="nounderline abstract_t">Smith JA, Mo Q, Guo H, et al. Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res 1995; 683:264.</a></li><li><a class="nounderline abstract_t">Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004; 9:984.</a></li><li class="breakAll">Curry SC, O'Connor AD, Graeme KA, Kang AM. Neurotransmitters and neuromodulators. In: Goldfrank's Toxicologic Emergencies, 11th edition, Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LS, Hoffman RS (Eds), McGraw Hill, New York, NY 2019. p.203.</li><li><a class="nounderline abstract_t">Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989; 321:1557.</a></li><li><a class="nounderline abstract_t">Kugelmass AD, Oda A, Monahan K, et al. Activation of human platelets by cocaine. Circulation 1993; 88:876.</a></li><li><a class="nounderline abstract_t">Rezkalla SH, Mazza JJ, Kloner RA, et al. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol 1993; 72:243.</a></li><li><a class="nounderline abstract_t">Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1994; 1:330.</a></li><li><a class="nounderline abstract_t">Koppel BS, Samkoff L, Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia 1996; 37:875.</a></li><li><a class="nounderline abstract_t">Fisher A, Holroyd BR. Cocaine-associated dissection of the thoracic aorta. J Emerg Med 1992; 10:723.</a></li><li><a class="nounderline abstract_t">Kolodgie FD, Wilson PS, Cornhill JF, et al. Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: the role of vascular endothelium. Toxicol Pathol 1993; 21:425.</a></li><li><a class="nounderline abstract_t">Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 1990; 65:303.</a></li><li><a class="nounderline abstract_t">Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA 1998; 279:1795.</a></li><li><a class="nounderline abstract_t">Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 1990; 88:325.</a></li><li><a class="nounderline abstract_t">Daras M, Tuchman AJ, Marks S. Central nervous system infarction related to cocaine abuse. Stroke 1991; 22:1320.</a></li><li><a class="nounderline abstract_t">Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 1990; 323:699.</a></li><li><a class="nounderline abstract_t">Ramadan NM, Levine SR, Welch KM. Pontine hemorrhage following "crack" cocaine use. Neurology 1991; 41:946.</a></li><li><a class="nounderline abstract_t">Schwartz KA, Cohen JA. Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol 1984; 41:705.</a></li><li><a class="nounderline abstract_t">Farooque U, Okorie N, Kataria S, et al. Cocaine-Induced Headache: A Review of Pathogenesis, Presentation, Diagnosis, and Management. Cureus 2020; 12:e10128.</a></li><li><a class="nounderline abstract_t">Maeder M, Ullmer E. Pneumomediastinum and bilateral pneumothorax as a complication of cocaine smoking. Respiration 2003; 70:407.</a></li><li><a class="nounderline abstract_t">Savader SJ, Omori M, Martinez CR. Pneumothorax, pneumomediastinum, and pneumopericardium: complications of cocaine smoking. J Fla Med Assoc 1988; 75:151.</a></li><li><a class="nounderline abstract_t">Uva JL. Spontaneous pneumothoraces, pneumomediastinum, and pneumoperitoneum: consequences of smoking crack cocaine. Pediatr Emerg Care 1997; 13:24.</a></li><li><a class="nounderline abstract_t">Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med 1989; 87:664.</a></li><li><a class="nounderline abstract_t">Osborn HH, Tang M, Bradley K, Duncan BR. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med 1997; 4:689.</a></li><li><a class="nounderline abstract_t">Rome LA, Lippmann ML, Dalsey WC, et al. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000; 117:1324.</a></li><li><a class="nounderline abstract_t">Delaney K, Hoffman RS. Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year-old woman. Am J Med 1991; 91:92.</a></li><li><a class="nounderline abstract_t">Smith GT, McClaughry PL, Purkey J, Thompson W. Crack cocaine mimicking pulmonary embolism on pulmonary ventilation/perfusion lung scan. A case report. Clin Nucl Med 1995; 20:65.</a></li><li><a class="nounderline abstract_t">Lee HS, LaMaute HR, Pizzi WF, et al. Acute gastroduodenal perforations associated with use of crack. Ann Surg 1990; 211:15.</a></li><li><a class="nounderline abstract_t">Pecha RE, Prindiville T, Pecha BS, et al. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers. Am J Gastroenterol 1996; 91:2523.</a></li><li><a class="nounderline abstract_t">Sharma R, Organ CH Jr, Hirvela ER, Henderson VJ. Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation. Am J Surg 1997; 174:629.</a></li><li><a class="nounderline abstract_t">Novielli KD, Chambers CV. Splenic infarction after cocaine use. Ann Intern Med 1991; 114:251.</a></li><li><a class="nounderline abstract_t">Edmondson DA, Towne JB, Foley DW, et al. Cocaine-induced renal artery dissection and thrombosis leading to renal infarction. WMJ 2004; 103:66.</a></li><li><a class="nounderline abstract_t">Kothur R, Marsh F, Posner G. Liver function tests in nonparenteral cocaine users. Arch Intern Med 1991; 151:1126.</a></li><li><a class="nounderline abstract_t">Flaque-Coma J. Cocaine and rhabdomyolysis: report of a case and review of the literature. Bol Asoc Med P R 1990; 82:423.</a></li><li><a class="nounderline abstract_t">Hoffman RS, Reimer BI. "Crack" cocaine-induced bilateral amblyopia. Am J Emerg Med 1993; 11:35.</a></li><li><a class="nounderline abstract_t">Libman RB, Masters SR, de Paola A, Mohr JP. Transient monocular blindness associated with cocaine abuse. Neurology 1993; 43:228.</a></li><li><a class="nounderline abstract_t">Ravin JG, Ravin LC. Blindness due to illicit use of topical cocaine. Ann Ophthalmol 1979; 11:863.</a></li><li><a class="nounderline abstract_t">Addis A, Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001; 15:341.</a></li><li><a class="nounderline abstract_t">Flowers D, Clark JF, Westney LS. Cocaine intoxication associated with abruptio placentae. J Natl Med Assoc 1991; 83:230.</a></li><li><a class="nounderline abstract_t">Rosenberg NM, Meert KL, Knazik SR, et al. Occult cocaine exposure in children. Am J Dis Child 1991; 145:1430.</a></li><li><a class="nounderline abstract_t">Buchanan JA, Heard K, Burbach C, et al. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 2011; 305:1657.</a></li><li><a class="nounderline abstract_t">Schneider S, Meys F. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010. Forensic Sci Int 2011; 212:242.</a></li><li><a class="nounderline abstract_t">Gross RL, Brucker J, Bahce-Altuntas A, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol 2011; 30:1385.</a></li><li><a class="nounderline abstract_t">Muirhead TT, Eide MJ. Images in clinical medicine. Toxic effects of levamisole in a cocaine user. N Engl J Med 2011; 364:e52.</a></li><li><a class="nounderline abstract_t">Lung D, Lynch K, Agrawal S, et al. Images in emergency medicine. Adult female with rash on lower extremities. Vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine. Ann Emerg Med 2011; 57:307, 311.</a></li><li><a class="nounderline abstract_t">Midthun KM, Nelson LS, Logan BK. Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review. Ther Drug Monit 2021; 43:221.</a></li><li><a class="nounderline abstract_t">Vagi SJ, Sheikh S, Brackney M, et al. Passive multistate surveillance for neutropenia after use of cocaine or heroin possibly contaminated with levamisole. Ann Emerg Med 2013; 61:468.</a></li><li><a class="nounderline abstract_t">Chai PR, Bastan W, Machan J, et al. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med 2011; 18:1141.</a></li><li><a class="nounderline abstract_t">Kudlacek O, Hofmaier T, Luf A, et al. Cocaine adulteration. J Chem Neuroanat 2017; 83-84:75.</a></li><li><a class="nounderline abstract_t">Hofmaier T, Luf A, Seddik A, et al. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int 2014; 73:32.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1381.</a></li><li><a class="nounderline abstract_t">Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med 2012; 60:94.</a></li><li><a class="nounderline abstract_t">Broséus J, Gentile N, Esseiva P. The cutting of cocaine and heroin: A critical review. Forensic Sci Int 2016; 262:73.</a></li><li><a class="nounderline abstract_t">Pope JD, Drummer OH, Schneider HG. The cocaine cutting agent levamisole is frequently detected in cocaine users. Pathology 2018; 50:536.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Atypical reactions associated with heroin use--five states, January-April 2005. MMWR Morb Mortal Wkly Rep 2005; 54:793.</a></li><li><a class="nounderline abstract_t">Nolan ML, Shamasunder S, Colon-Berezin C, et al. Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention. J Urban Health 2019; 96:49.</a></li><li><a class="nounderline abstract_t">Mattson CL, Tanz LJ, Quinn K, et al. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep 2021; 70:202.</a></li><li><a class="nounderline abstract_t">Khatri UG, Viner K, Perrone J. Lethal Fentanyl and Cocaine Intoxication. N Engl J Med 2018; 379:1782.</a></li><li><a class="nounderline abstract_t">Klar SA, Brodkin E, Gibson E, et al. Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:1015.</a></li><li><a class="nounderline abstract_t">Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review. Clin Toxicol (Phila) 2016; 54:345.</a></li><li><a class="nounderline abstract_t">Richards JR, Lange RA, Arnold TC, Horowitz BZ. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol. Am J Emerg Med 2017; 35:519.e1.</a></li><li><a class="nounderline abstract_t">Öcal L, Çakir H, Tellice M, et al. Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy. Herz 2015; 40:159.</a></li><li><a class="nounderline abstract_t">Lo KB, Virk HUH, Lakhter V, et al. Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis. Am J Med 2019; 132:505.</a></li><li><a class="nounderline abstract_t">Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008; 51:127.</a></li><li><a class="nounderline abstract_t">Richards JR, Hollander JE, Ramoska EA, et al. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. J Cardiovasc Pharmacol Ther 2017; 22:239.</a></li><li><a class="nounderline abstract_t">Rappolt RT, Gay G, Inaba DS, Rappolt NR. Propranolo in cocaine toxicity. Lancet 1976; 2:640.</a></li><li><a class="nounderline abstract_t">Rappolt RT Sr, Gray GR, Inaba DS. Letter: Propranolol in the treatment of cardiopressor effect of cocaine. N Engl J Med 1976; 295:448.</a></li><li><a class="nounderline abstract_t">Pham D, Addison D, Kayani W, et al. Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emerg Med J 2018; 35:559.</a></li><li><a class="nounderline abstract_t">Armstrong LE, Crago AE, Adams R, et al. Whole-body cooling of hyperthermic runners: comparison of two field therapies. Am J Emerg Med 1996; 14:355.</a></li><li><a class="nounderline abstract_t">Costrini A. Emergency treatment of exertional heatstroke and comparison of whole body cooling techniques. Med Sci Sports Exerc 1990; 22:15.</a></li><li><a class="nounderline abstract_t">Gaffin SL, Gardner JW, Flinn SD. Cooling methods for heatstroke victims. Ann Intern Med 2000; 132:678.</a></li><li><a class="nounderline abstract_t">Tomaszewski C, McKinney P, Phillips S, et al. Prevention of toxicity from oral cocaine by activated charcoal in mice. Ann Emerg Med 1993; 22:1804.</a></li><li><a class="nounderline abstract_t">Weber JE, Chudnofsky CR, Boczar M, et al. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med 2000; 7:873.</a></li><li><a class="nounderline abstract_t">Hollander JE, Lozano M, Fairweather P, et al. "Abnormal" electrocardiograms in patients with cocaine-associated chest pain are due to "normal" variants. J Emerg Med 1994; 12:199.</a></li><li><a class="nounderline abstract_t">Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351.</a></li><li><a class="nounderline abstract_t">Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995; 333:1267.</a></li><li><a class="nounderline abstract_t">Albertson TE, Dawson A, de Latorre F, et al. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 37:S78.</a></li><li><a class="nounderline abstract_t">Chan GM, Sharma R, Price D, et al. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). J Med Toxicol 2006; 2:108.</a></li><li><a class="nounderline abstract_t">Mott SH, Packer RJ, Soldin SJ. Neurologic manifestations of cocaine exposure in childhood. Pediatrics 1994; 93:557.</a></li><li><a class="nounderline abstract_t">Bateman DA, Heagarty MC. Passive freebase cocaine ('crack') inhalation by infants and toddlers. Am J Dis Child 1989; 143:25.</a></li><li><a class="nounderline abstract_t">Claudet I, Caula C, Gallart JC, et al. A French study of cocaine intoxication/exposure in children (2010-2020). Clin Toxicol (Phila) 2023; 61:370.</a></li><li><a class="nounderline abstract_t">Lustbader AS, Mayes LC, McGee BA, et al. Incidence of passive exposure to crack/cocaine and clinical findings in infants seen in an outpatient service. Pediatrics 1998; 102:e5.</a></li><li><a class="nounderline abstract_t">Armenian P, Fleurat M, Mittendorf G, Olson KR. Unintentional Pediatric Cocaine Exposures Result in Worse Outcomes than Other Unintentional Pediatric Poisonings. J Emerg Med 2017; 52:825.</a></li><li><a class="nounderline abstract_t">Hollander JE, Hoffman RS, Gennis P, et al. Cocaine-associated chest pain: one-year follow-up. Acad Emerg Med 1995; 2:179.</a></li><li><a class="nounderline abstract_t">Weber JE, Shofer FS, Larkin GL, et al. Validation of a brief observation period for patients with cocaine-associated chest pain. N Engl J Med 2003; 348:510.</a></li><li><a class="nounderline abstract_t">Cunningham R, Walton MA, Weber JE, et al. One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain. Ann Emerg Med 2009; 53:310.</a></li><li><a class="nounderline abstract_t">Singh V, Rodriguez AP, Thakkar B, et al. Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States. Am J Med 2017; 130:688.</a></li><li><a class="nounderline abstract_t">Walsh K, Chang AM, Perrone J, et al. Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain. J Med Toxicol 2009; 5:111.</a></li></ol></div><div id="topicVersionRevision">Topic 303 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.dea.gov/divisions/hq/2015/hq052215_National_Heroin_Threat_Assessment_Summary.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : National Heroin Threat Assessment Summary April 2015 https://www.dea.gov/divisions/hq/2015/hq052215_National_Heroin_Threat_Assessment_Summary.pdf (Accessed on November 29, 2016).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16054006" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Underlying causes of cocaine, amphetamine and opioid related deaths in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12780362" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12062462" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Deaths by unintentional illicit drug overdose in Italy, 1984-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760893" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Fatal injuries after cocaine use as a leading cause of death among young adults in New York City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2565204" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/639429" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Metabolism of cocaine in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15461242" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Ecgonine methyl ester protects against cocaine lethality in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8846107" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Effect of cocaine metabolites on behavior: possible neuroendocrine mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8002536" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9801727" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Alcohol dependence and mood disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9492381" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : In vitro transesterification of cocaethylene (ethylcocaine) in the presence of ethanol. esterase-mediated ethyl ester exchange esterase-mediated ethyl ester exchange.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14636972" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The pharmacology of cocaethylene in humans following cocaine and ethanol administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21463066" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cocaethylene formation following ethanol and cocaine administration by different routes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21463066" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cocaethylene formation following ethanol and cocaine administration by different routes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12215047" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cocaethylene's effects on coronary artery blood flow and cardiac function in a canine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1988563" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3315310" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Drug of abuse profile: cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1501115" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cardiovascular effects of cocaine in conscious rats: relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8229742" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2820058" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cocaine receptors on dopamine transporters are related to self-administration of cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7552364" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15278097" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Glutamate as a therapeutic target in psychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15278097" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Glutamate as a therapeutic target in psychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2573838" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cocaine-induced coronary-artery vasoconstriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7689042" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Activation of human platelets by cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8328397" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effects of cocaine on human platelets in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7614278" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8814101" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Relation of cocaine use to seizures and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1491155" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cocaine-associated dissection of the thoracic aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8115819" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: the role of vascular endothelium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2301258" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9628710" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ambient temperature and mortality from unintentional cocaine overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2327419" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cocaine-related medical problems: consecutive series of 233 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1926246" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Central nervous system infarction related to cocaine abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2388668" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2046953" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pontine hemorrhage following "crack" cocaine use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6743055" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Subarachnoid hemorrhage precipitated by cocaine snorting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33005542" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cocaine-Induced Headache: A Review of Pathogenesis, Presentation, Diagnosis, and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14512677" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pneumomediastinum and bilateral pneumothorax as a complication of cocaine smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3361277" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Pneumothorax, pneumomediastinum, and pneumopericardium: complications of cocaine smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9061731" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Spontaneous pneumothoraces, pneumomediastinum, and pneumoperitoneum: consequences of smoking crack cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2686434" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A review of the respiratory effects of smoking cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9223692" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10807818" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prevalence of cocaine use and its impact on asthma exacerbation in an urban population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1858836" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year-old woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7895442" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Crack cocaine mimicking pulmonary embolism on pulmonary ventilation/perfusion lung scan. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2403771" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Acute gastroduodenal perforations associated with use of crack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8946979" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Association of cocaine and methamphetamine use with giant gastroduodenal ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9409587" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical observation of the temporal association between crack cocaine and duodenal ulcer perforation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984755" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Splenic infarction after cocaine use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15696837" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Cocaine-induced renal artery dissection and thrombosis leading to renal infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2043014" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Liver function tests in nonparenteral cocaine users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2076148" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cocaine and rhabdomyolysis: report of a case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8447867" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : "Crack" cocaine-induced bilateral amblyopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8423897" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Transient monocular blindness associated with cocaine abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/496179" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Blindness due to illicit use of topical cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11489591" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Fetal effects of cocaine: an updated meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2038082" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cocaine intoxication associated with abruptio placentae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1669673" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Occult cocaine exposure in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21521846" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21767923" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21706168" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21675882" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Images in clinical medicine. Toxic effects of levamisole in a cocaine user.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21353913" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Images in emergency medicine. Adult female with rash on lower extremities. Vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33298746" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23374417" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Passive multistate surveillance for neutropenia after use of cocaine or heroin possibly contaminated with levamisole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22092895" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Levamisole exposure and hematologic indices in cocaine users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28619473" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Cocaine adulteration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24296074" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20019655" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Agranulocytosis associated with cocaine use - four States, March 2008-November 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21958733" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26974713" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The cutting of cocaine and heroin: A critical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29937233" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The cocaine cutting agent levamisole is frequently detected in cocaine users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16107783" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Atypical reactions associated with heroin use--five states, January-April 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30635841" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33571180" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30380395" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Lethal Fentanyl and Cocaine Intoxication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27657853" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26919414" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Treatment of cocaine cardiovascular toxicity: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27707569" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24173375" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30562494" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17889405" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Cocaine and beta-blockers: should the controversy continue?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28399647" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : β-Blockers, Cocaine, and the Unopposedα-Stimulation Phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/61383" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Propranolo in cocaine toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/934248" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Letter: Propranolol in the treatment of cardiopressor effect of cocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29921621" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8768154" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Whole-body cooling of hyperthermic runners: comparison of two field therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2406541" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Emergency treatment of exertional heatstroke and comparison of whole body cooling techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10766695" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Cooling methods for heatstroke victims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8239099" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Prevention of toxicity from oral cocaine by activated charcoal in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10958126" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Cocaine-associated chest pain: how common is myocardial infarction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8207156" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : "Abnormal" electrocardiograms in patients with cocaine-associated chest pain are due to "normal" variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11484693" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Cardiovascular complications of cocaine use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7566005" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The management of cocaine-associated myocardial ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11290973" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : TOX-ACLS: toxicologic-oriented advanced cardiac life support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18072128" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8134208" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Neurologic manifestations of cocaine exposure in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2910042" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Passive freebase cocaine ('crack') inhalation by infants and toddlers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37183679" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : A French study of cocaine intoxication/exposure in children (2010-2020).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9651457" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Incidence of passive exposure to crack/cocaine and clinical findings in infants seen in an outpatient service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28408236" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Unintentional Pediatric Cocaine Exposures Result in Worse Outcomes than Other Unintentional Pediatric Poisonings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7497030" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Cocaine-associated chest pain: one-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12571258" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Validation of a brief observation period for patients with cocaine-associated chest pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18824277" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28063854" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19655282" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
